Granules India Limited acquires the Swiss-based company Senn Chemicals AG

One of the leading pharmaceutical companies, Granules India based in Hyderabad recently acquired Senn Chemicals AG, a Swiss-based contract development and manufacturing organization. Senn Chemicals specializes in peptide development and manufacture.

The Hyderabad-based Indian multinational pharmaceutical manufacturing company completed the share purchase in February 2025 and bought Senn Chemicals from the founding family at a whopping INR 192.5 crore.

The Chairman and Managing Director of Granules India, Krishna Prasad Chigurupati, “The acquisition of Senn Chemicals AG marks a pivotal step in Granules’ strategic evolution into a science and innovation-led organization. By entering the rapidly growing peptide therapeutics segment and building on Senn’s specialized CDMO capabilities, we are well positioned to deliver high-quality, next-generation treatments,”

Established in 1963 in Dielsdorf, Switzerland, Senn Chemicals AG has specialized in peptides and amino acid derivatives. Their solid-phase and liquid-phase peptide synthesis has been serving the pharma, biotechnology, diagnostic, and cosmetic industries all around the world.

Acquiring Senn Chemicals will boost Granules India’s aim to increase its product lines and also create a strong foot in the global pharmaceutical industry. Granules India is preparing to accelerate their complex generics and innovative therapeutics. With the world class access to the pharmaceutical industry and positioning India globally.

The acquisition of Senn Chemicals is expected to bring Granules India a competitive edge in the peptide API segment. This segment is growing rapidly and catering to specialized and high-quality pharmaceutical ingredients.

Granules India is about to broaden their products and services, acting as a key player in the pharmaceutical industry. Granules right now manufacture active pharmaceutical ingredients (API), Pharmaceutical Formulation Intermediates (PFIs), and Finished Dosages (FDs) in over 55 countries. The acquisition will bolster their distribution even more with more products in the portfolio.